Immuneering Corporation

NASDAQ:IMRX

1.45 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 36.14545.20659.72866.28759.40668.04104.01777.4372.63776.41887.93775.20574.888106.92850.24530.93437.09-13.782
Short Term Investments 05.45204.99126.2629.2024.96814.10632.88840.77940.16462.56674.31142.5500027.564
Cash and Short Term Investments 36.14550.65859.72871.27885.66697.243108.98591.536105.525117.197128.101137.771149.199149.47850.24530.93437.0913.782
Net Receivables 00000000.0010.0120.070.1780.280.2460.4710.4950.4920.50
Inventory 000000000000000000
Other Current Assets 3.44303.9573.1693.4183.342.5222.6973.212.7570.891.482.8893.3610.6970.7570.1410
Total Current Assets 39.58855.2663.68674.44789.084100.583111.50794.234108.747120.025129.17139.53152.334153.31151.43732.18337.73113.782
Non-Current Assets:
Property, Plant & Equipment, Net 4.794.9545.1185.2535.3965.4775.565.6275.7775.8235.6765.7066.1310.6190.6450.660.6770
Goodwill 6.696.696.696.696.696.696.696.696.696.696.696.696.70200000
Intangible Assets 0.350.3580.3650.3720.380.3870.3940.4020.4090.4160.4240.4310.43900000
Goodwill and Intangible Assets 7.0417.0487.0557.0637.077.0777.0857.0927.0997.1077.1147.1217.14100000
Long Term Investments 0000004,962.87214,091.45400000.99710.0990000
Tax Assets 000000-4,962.872-14,091.4540000000000
Other Non-Current Assets 1.2961.2961.2281.2191.0340.7440.7440.7440.7440.7370.090.090.1020.0140.960.0140.014-13.782
Total Non-Current Assets 13.12713.29813.40213.53513.50113.29813.38813.46313.6213.66712.8812.91714.37110.7321.6050.6740.692-13.782
Total Assets 52.71468.55777.08787.983102.585113.881124.895107.696122.367133.692142.05152.447166.705164.04253.04232.85738.4230
Liabilities & Equity:
Current Liabilities:
Account Payables 1.9591.9432.6222.2712.1121.9412.6932.7243.1552.3381.241.6421.3941.7951.4331.3691.4810
Short Term Debt 0.3380.3250.3110.2990.30.3020.3330.3630.3790.3090.2860.2650.2740.0830.0810.0780.0760
Tax Payables 000000000000000000
Deferred Revenue 00005.17402.4270002.2270000000
Other Current Liabilities 5.2074.6523.8472.6085.4343.382.4532.4394.5214.6092.2741.7663.9653.3893.3191.3110.6990
Total Current Liabilities 7.5046.926.7815.1777.8465.6225.4795.5268.0547.2563.8013.6745.6345.2674.8322.7582.2560
Non-Current Liabilities:
Long Term Debt 3.8243.9164.0014.0834.1634.2414.3124.3814.4634.5434.6454.7085.0910.4820.5030.5240.5450
Deferred Revenue Non-Current 000000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000
Other Non-Current Liabilities 00000000000.010.010082.893058.1040
Total Non-Current Liabilities 3.8243.9164.0014.0834.1634.2414.3124.3814.4634.5434.6554.7175.0910.48283.3960.52458.6490
Total Liabilities 11.32810.83610.7829.2612.0089.8639.7919.90712.51711.7988.4558.39110.7255.74988.2283.28260.9040
Equity:
Preferred Stock 0000000000000164,042.39161,772.76158.10458.10416.612
Common Stock 0.0310.0310.030.030.0290.0290.0290.0260.0260.0260.0260.0260.0260.0260.0050.0140.0050
Retained Earnings -224.295-206.244-191.646-177.566-163.259-148.175-135.58-123.391-109.787-96.541-83.697-72.17-59.273-48.489-39.955-31.967-25.7380
Accumulated Other Comprehensive Income/Loss 00.0080-0.001-0.0010.006-0.0020.001-0.03-0.142-0.182-0.167-0.049-0.005-149,424.598-58.104-58.104-6.528
Other Total Stockholders Equity 265.65263.926257.922256.261253.806252.158250.657221.154219.641218.551217.447216.367215.276-163,835.634.764119.64361.3550
Total Shareholders Equity 41.38657.72166.30678.72390.576104.018115.10497.79109.85121.893133.595144.056155.98158.294-35.18629.575-22.48110.084
Total Equity 41.38657.72166.30678.72390.576104.018115.10497.79109.85121.893133.595144.056155.98158.294-35.18629.575-22.48110.084
Total Liabilities & Shareholders Equity 52.71468.55777.08787.983102.585113.881124.895107.696122.367133.692142.05152.447166.705164.04253.04232.85738.42310.084